No transactions effected at NASDAQ OMX Armenia stock exchange

YEREVAN, December 1. /ARKA/. No transactions in USD and Euros were effected today at NASDAQ OMX Armenia stock exchange, according to data provided to ARKA news agency. Asked by ARKA to comment on the reluctance of players to buy or sell foreign currency the executive director of Renesa investment company, Vaghinak Saroyan, explained it by the refusal of players to make mutual concessions.

“After yesterday trading when the USD was traded at 381 drams, the players were willing to buy the dollar at this price, but the sellers raised the rate to 381.5 drams,” he said.

Saroyan also added that the depreciation of the greenback’s exchange rate at the end of November was a natural process that leads to rise of the rate in early December and therefore the supply of dollars at the stock exchange was higher than yesterday.

The latest transaction in foreign currency at the stock exchange was registered on 30th of November, when USD traded at 381 drams for $ 1. At the same time, the Central Bank of Armenia raised on December 1 the average rate of U.S. dollar against the Armenian dram by 0.06 points as compared with November 30 setting it at 381.06 drams.  -0-

spot_img

POPULAR

An Armenian Business Founded in a Garage: Games for Live Communication with the Support of Acba Bank

The success story of board games created by David Hovhannisyan began in a small garage near his home. David and his friends created educational games during their student years; as the number of orders grew, they decided to expand the business.

Armenian banks will provide citizens with account statements free of charge

Individuals in Armenia will be able to receive free electronic statements from commercial banks about their bank accounts, their balances, and the presence or absence of mutual obligations with the bank.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

Armbanks Weekly Digest: Key Events in the Armenian Financial Market (August 17–23)

Key developments in Armenia's financial market this week included new banking compliance requirements, measures against account fraud, and decisions related to capital market development.

LATEST NEWS

spot_imgspot_imgspot_img